Labcorp EVP Vaughn reports RSU vesting, tax share sales

Labcorp Holdings Inc. executive Bryan T. Vaughn reported routine equity compensation activity.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Labcorp Holdings Inc. executive Bryan T. Vaughn reported routine equity compensation activity. As EVP, Diagnostics, he exercised restricted stock units (RSUs) into common stock on February 6 and 7, 2026, with corresponding increases in directly owned shares.

On February 6 and 9, 2026, small blocks of common stock were withheld and disposed of under code "F" at prices of $277.2 and $274.01 per share to satisfy tax withholding obligations, as noted in the footnotes. Following these transactions, he directly owned about 5,382.5702 shares of Labcorp common stock and 3,624 RSUs, which each represent the right to receive one share upon settlement.

Insider Trade Summary

358 shares exercised/converted

Exercise 6 txns

Insider Vaughn Bryan T

Role EVP, Diagnostics

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	61	$274.01	$17K
Exercise	Restricted Stock Unit	178	$0.00	$0.00
Exercise	Common Stock	178	$0.00	$0.00
Exercise	Restricted Stock Unit	180	$0.00	$0.00
Exercise	Common Stock	180	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	61	$277.20	$17K

Holdings After Transaction: Restricted Stock Unit — 3,624 contracts (Direct); Common Stock — 5,382.5702 shares (Direct)

Footnotes (5)

F1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
F2. Stock withholding to satisfy tax withholding obligations.
F3. The Restricted Stock Units that have vested were part of a grant that vests in two equal annual installments beginning on February 6, 2026.
F4. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
F5. The Restricted Stock Units vested on February 7, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Labcorp (LH) EVP Bryan T. Vaughn report?

Bryan T. Vaughn reported the exercise of restricted stock units into Labcorp common stock and related tax withholding transactions. RSUs converted to shares on February 6 and 7, 2026, with shares withheld and disposed of to cover tax obligations as reflected by transaction code "F."

How many Labcorp (LH) shares does Bryan T. Vaughn own after these Form 4 transactions?

After the reported transactions, Bryan T. Vaughn directly owns 5,382.5702 shares of Labcorp common stock. He also holds 3,624 restricted stock units, each representing a contingent right to receive one additional Labcorp share upon settlement or vesting, according to the filing footnotes.

What do the RSU transactions mean in Bryan T. Vaughn’s Labcorp (LH) Form 4?

The RSU transactions reflect equity awards vesting and being converted into Labcorp common stock. Each restricted stock unit represents the right to receive one share, and the filing notes these units were part of a grant vesting in two equal annual installments beginning February 6, 2026.

Why were some Labcorp (LH) shares reported with transaction code "F" on the Form 4?

Transaction code "F" indicates shares were withheld to satisfy tax withholding obligations when equity awards vested. The filing explains that certain Labcorp shares were disposed of at specified prices solely to cover taxes, rather than as discretionary open-market sales by the executive.

When did Bryan T. Vaughn’s Labcorp (LH) restricted stock units vest?

According to the footnotes, part of Vaughn’s RSU grant vests in two equal annual installments beginning on February 6, 2026. Another footnote specifies that a portion of the restricted stock units vested on February 7, 2026, triggering the related share issuances and tax withholdings.

How are Labcorp (LH) restricted stock units defined in this Form 4?

The filing states that each Labcorp restricted stock unit represents the contingent right to receive one share of Labcorp Holdings Inc. common stock. A separate footnote clarifies that the reported RSU balance reflects the aggregate number of units still held by the reporting person after the transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/10/2026 - 03:05 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vaughn Bryan T

(Last)

(First)

(Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON

27215

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, Diagnostics

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/06/2026		M		180	A	⁽¹⁾	5,326.5702	D
Common Stock	02/06/2026		F⁽²⁾		61	D	$277.2	5,265.5702	D
Common Stock	02/07/2026		M		178	A	⁽¹⁾	5,443.5702	D
Common Stock	02/09/2026		F⁽²⁾		61	D	$274.01	5,382.5702	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	02/06/2026		M			180	⁽³⁾	⁽³⁾	Common Stock	180	$0	3,802⁽⁴⁾	D
Restricted Stock Unit	⁽¹⁾	02/07/2026		M			178	⁽⁵⁾	⁽⁵⁾	Common Stock	178	$0	3,624⁽⁴⁾	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. Stock withholding to satisfy tax withholding obligations.

3. The Restricted Stock Units that have vested were part of a grant that vests in two equal annual installments beginning on February 6, 2026.

4. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

5. The Restricted Stock Units vested on February 7, 2026.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Bryan T. Vaughn	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR